Houghton M - Search Results

1

HCV E1E2-MF59 vaccine in chronic hepatitis C patients treated with PEG-IFNα2a and Ribavirin: a randomized controlled trial.

Colombatto P, Brunetto MR, Maina AM, Romagnoli V, Almasio P, Rumi MG, Ascione A, Pinzello G, Mondelli M, Muratori L, Rappuoli R, Rosa D, Houghton M, Abrignani S, Bonino F. Colombatto P, et al. Among authors: houghton m. J Viral Hepat. 2014 Jul;21(7):458-65. doi: 10.1111/jvh.12163. Epub 2013 Aug 27. J Viral Hepat. 2014. PMID: 24750327 Free PMC article. Clinical Trial.

2

Compartmentalization of T lymphocytes to the site of disease: intrahepatic CD4+ T cells specific for the protein NS4 of hepatitis C virus in patients with chronic hepatitis C.

Minutello MA, Pileri P, Unutmaz D, Censini S, Kuo G, Houghton M, Brunetto MR, Bonino F, Abrignani S. Minutello MA, et al. Among authors: houghton m. J Exp Med. 1993 Jul 1;178(1):17-25. doi: 10.1084/jem.178.1.17. J Exp Med. 1993. PMID: 8100267 Free PMC article.

3

Perspectives for a vaccine against hepatitis C virus.

Abrignani S, Houghton M, Hsu HH. Abrignani S, et al. Among authors: houghton m. J Hepatol. 1999;31 Suppl 1:259-63. doi: 10.1016/s0168-8278(99)80413-9. J Hepatol. 1999. PMID: 10622599 Review.

4

Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults.

Frey SE, Houghton M, Coates S, Abrignani S, Chien D, Rosa D, Pileri P, Ray R, Di Bisceglie AM, Rinella P, Hill H, Wolff MC, Schultze V, Han JH, Scharschmidt B, Belshe RB. Frey SE, et al. Among authors: houghton m. Vaccine. 2010 Aug 31;28(38):6367-73. doi: 10.1016/j.vaccine.2010.06.084. Epub 2010 Jul 7. Vaccine. 2010. PMID: 20619382 Free PMC article. Clinical Trial.

5

High prevalence of G1 and G2 TT-virus infection in subjects with high and low blood exposure risk: identification of G4 isolates in Italy.

Colombatto P, Brunetto MR, Kansopon J, Oliveri F, Maina A, Aragon U, Bortoli ML, Scatena F, Baicchi U, Houghton M, Bonino F, Weiner AJ. Colombatto P, et al. Among authors: houghton m. J Hepatol. 1999 Dec;31(6):990-6. doi: 10.1016/s0168-8278(99)80310-9. J Hepatol. 1999. PMID: 10604571

6

Prospects for a hepatitis C virus vaccine.

Hsu HH, Abrignani S, Houghton M. Hsu HH, et al. Among authors: houghton m. Clin Liver Dis. 1999 Nov;3(4):901-15. doi: 10.1016/s1089-3261(05)70246-4. Clin Liver Dis. 1999. PMID: 11291258 Review.

7

Prospects for a vaccine against the hepatitis C virus.

Houghton M, Abrignani S. Houghton M, et al. Nature. 2005 Aug 18;436(7053):961-6. doi: 10.1038/nature04081. Nature. 2005. PMID: 16107836 Review.

8

Hepatitis C virus markers in patients with long-term biochemical and histological remission of chronic hepatitis.

Saracco G, Abate ML, Baldi M, Calvo PL, Manzini P, Brunetto MR, Oliveri F, Kuo G, Chien D, Houghton M, et al. Saracco G, et al. Among authors: houghton m. Liver. 1994 Apr;14(2):65-70. doi: 10.1111/j.1600-0676.1994.tb00049.x. Liver. 1994. PMID: 7515141

9

Hepatitis C virus polyprotein vaccine formulations capable of inducing broad antibody and cellular immune responses.

Vajdy M, Selby M, Medina-Selby A, Coit D, Hall J, Tandeske L, Chien D, Hu C, Rosa D, Singh M, Kazzaz J, Nguyen S, Coates S, Ng P, Abrignani S, Lin YL, Houghton M, O'Hagan DT. Vajdy M, et al. Among authors: houghton m. J Gen Virol. 2006 Aug;87(Pt 8):2253-2262. doi: 10.1099/vir.0.81849-0. J Gen Virol. 2006. PMID: 16847121

10

Characterization of antibodies induced by vaccination with hepatitis C virus envelope glycoproteins.

Ray R, Meyer K, Banerjee A, Basu A, Coates S, Abrignani S, Houghton M, Frey SE, Belshe RB. Ray R, et al. Among authors: houghton m. J Infect Dis. 2010 Sep 15;202(6):862-6. doi: 10.1086/655902. J Infect Dis. 2010. PMID: 20677942 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

316 results

Search Page